Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Goodwill (2016 - 2025)

Standard Biotools (LAB) has disclosed Goodwill for 12 consecutive years, with $111.7 million as the latest value for Q1 2025.

  • Quarterly Goodwill rose 5.13% to $111.7 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $111.7 million through Mar 2025, up 5.13% year-over-year, with the annual reading at $111.3 million for FY2024, 4.68% up from the prior year.
  • Goodwill for Q1 2025 was $111.7 million at Standard Biotools, roughly flat from $111.3 million in the prior quarter.
  • The five-year high for Goodwill was $111.7 million in Q1 2025, with the low at $106.1 million in Q3 2022.
  • Average Goodwill over 5 years is $106.9 million, with a median of $106.3 million recorded in 2023.
  • The sharpest move saw Goodwill soared 4738.91% in 2021, then dropped 0.34% in 2022.
  • Over 5 years, Goodwill stood at $106.4 million in 2021, then decreased by 0.12% to $106.3 million in 2022, then increased by 0.06% to $106.3 million in 2023, then rose by 4.68% to $111.3 million in 2024, then rose by 0.38% to $111.7 million in 2025.
  • According to Business Quant data, Goodwill over the past three periods came in at $111.7 million, $111.3 million, and $106.3 million for Q1 2025, Q4 2024, and Q3 2024 respectively.